Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0419 per EA under NDC 16571075501. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571075501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078777FDA Approved
9/11/2012
TE Code
AB
On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0419 per EA |
|---|---|
| All-time high | $0.0501 (Apr 10, 2024) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0472 |
| 52-week low | $0.0412 |
| Median price | $0.0434 |
| Average price | $0.0435 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0419 per EA (NDC 16571075501), effective Aug 19, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 6.6%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Oct 11, 2023, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0434 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESCITALOPRAM 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 16571075501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.